Glimda Mv 2 Tablet

Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)

Uses of Glimda Mv 2 Tablet

Type 2 diabetes mellitus, Control of post‑meal (postprandial) blood glucose in type 2 diabetes when diet and exercise alone are insufficient

• •Helps control fasting and post‑meal blood sugar
• •Improves overall glycaemic control (HbA1c) when used with diet and exercise
• •Reduces postprandial glucose spikes
• •Supports better insulin utilization and lowers hepatic glucose output

How it works

Glimepiride increases insulin release from the pancreas and improves insulin sensitivity. Metformin reduces glucose production in the liver and improves peripheral glucose uptake. Voglibose delays intestinal carbohydrate absorption, reducing post‑meal glucose spikes.

Directions for use

Take exactly as prescribed. Usually taken once daily with/just before the first main meal; swallow tablet whole (do not crush/chew, especially for modified‑release metformin). Monitor blood glucose regularly and follow diet/exercise advice.

Side effects

Common side effects of Glimda Mv 2 Tablet may include:

• •Nausea
• •diarrhea
• •abdominal pain
• •flatulence
• •headache